Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function

Clinical trial NCT00851227 · COMPLETED

Trial details

NCT number: NCT00851227
Sponsor: Cumberland Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Liver Disease Hyponatremia

Start date: 2009-02-01
Primary completion: 2010-01-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.